Gilead Sciences (Brazil) Widgets and Gadgets
GILD34 Stock | BRL 287.56 4.47 1.58% |
Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- GILD34 Gilead Sciences
- GILD34 287.56 4.47
- Low 287.56
- High 287.56
- Alpha 0.35
- Beta 0.0457
- Return On Equity 0.22
- Return On Asset 0.1
- Profit Margin 0.17 %
- Operating Margin 0.40 %
- Current Valuation 686.18 B
- Shares Outstanding 2.49 B
- Price To Earning 28.35 X
- Price To Book 5.30 X
- Price To Sales 21.27 X
- Revenue 27.28 B
- Gross Profit 21.62 B
- EBITDA 6.75 B
- Net Income 4.59 B
- Cash And Equivalents 28.36 B
- Cash Per Share 22.39 X
- Total Debt 25.18 B
- Debt To Equity 117.00 %
- Current Ratio 3.76 X
- Book Value Per Share 17.01 X
- Cash Flow From Operations 9.07 B
- Earnings Per Share 9.63 X
- Price To Earnings To Growth 0.71 X
- Number Of Employees 31
- Beta 0.41
- Market Capitalization 572.2 B
- Total Asset 63.17 B
- Z Score 13.2
- Annual Yield 0.03 %
- Net Asset 63.17 B
- Last Dividend Paid 2.92
- Daily Balance Of Power 9.2 T
- Rate Of Daily Change 1.02
- Day Median Price 287.56
- Day Typical Price 287.56
- Price Action Indicator 2.24
- Period Momentum Indicator 4.47
Market Snapshot Widget Example
DAX Index Germany | 19,849 0.18 | |
Taiwan Weighted Taiwan | 23,120 0.07 | |
PSI 20 Stock Portugal | 6,326 0.32 | |
CROBEX Croatia | 3,204 0.17 | |
Budapest SE Hungary | 79,493 0.95 | |
IDX 30 Jakarta Indonesia | 424.36 0.55 | |
ISEQ 20 Price Ireland | 1,631 0.42 | |
NYSE Comp USA | 19,341 0.70 | |
Tel Aviv 35 Israel | 2,403 0.61 | |
Coreshares Index Tracker South Afric | 1,128 1.26 | |
IPC MEXICO Mexico | 49,317 0.59 | |
KL Technology Malaysia | 64.10 0.12 | |
IBEX 35 Index Spain | 11,474 0.33 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,607 0.50 | |
SPASX Dividend Opportunities Australia | 1,660 0.16 | |
HNX 30 Vietnam | 482.72 0.42 | |
Bucharest BET-NG Romania | 1,214 0.52 | |
AMS Small Cap Netherlands | 1,248 0.89 | |
Oslo Exchange Mutual Norway | 1,367 0.54 | |
BEL Small Belgium | 8,217 1.09 | |
Basic Materials Brazil | 5,571 0.52 | |
Swiss Leader Price Switzerland | 1,900 0.84 | |
Fondo Mutuo ETF Chile | 1,388 0.27 | |
Athens General Comp Greece | 1,449 0.25 | |
Stock Exchange Of Thailand | 1,395 0.56 | |
PX Prague Stock Czech Repub | 1,762 0.41 | |
THE PHILIPPINE STOCK Philippines | 6,535 2.01 | |
WIG 30 Poland | 2,814 0.13 | |
BIST Electricity Turkey | 498.04 0.21 |
Investing Ideas
In addition to having Gilead Sciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Gilead Sciences
Compare Gilead Sciences To Peers
Complementary Tools for Gilead Stock analysis
When running Gilead Sciences' price analysis, check to measure Gilead Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gilead Sciences is operating at the current time. Most of Gilead Sciences' value examination focuses on studying past and present price action to predict the probability of Gilead Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gilead Sciences' price. Additionally, you may evaluate how the addition of Gilead Sciences to your portfolios can decrease your overall portfolio volatility.
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Stocks Directory Find actively traded stocks across global markets |